Comparison of the long-term tolerability, pharmacodynamics, and safety of sandimmune and neoral in liver transplant recipients

Transplantation Proceedings

Volumn 28, Issue 4, 1996, Pages 2232-2233

  Grant, D ^a   Rochon, J ^a   Levy, G ^a   Cattral, M ^a   Cheung, S ^a   Greig, P ^a   Altraif, I ^a   Rezieg, M ^a   Wong, P Y ^a   Adams, P ^a   Asfar, S ^a   Freeman, D ^a   Ghent, C ^a   Wall, W ^a  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; METHYLPREDNISOLONE; OKT 3; THYMOCYTE ANTIBODY;

ADULT; AGED; BLOOD TOXICITY; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG SAFETY; DRUG TOLERABILITY; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; LIVER TRANSPLANTATION; NEUROTOXICITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, ORAL; ADULT; AGED; ANTILYMPHOCYTE SERUM; CYCLOSPORINE; DOSAGE FORMS; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; METHYLPREDNISOLONE; MIDDLE AGED; MUROMONAB-CD3; REOPERATION; SURVIVAL RATE;

EID: 0029809035     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (0)